Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lap… Read more
Treace Medical Concepts Inc (TMCI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.102x
Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has a cash flow conversion efficiency ratio of -0.102x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.09 Million) by net assets ($89.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Treace Medical Concepts Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Treace Medical Concepts Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Treace Medical Concepts Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Treace Medical Concepts Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
S H Kelkar and Company Limited
NSE:SHK
|
0.098x |
|
Socovesa
SN:SOCOVESA
|
-0.126x |
|
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IS:GENIL
|
0.018x |
|
East Tender Opto
TWO:6588
|
-0.033x |
|
PHA Co. Ltd
KQ:043370
|
0.033x |
|
Gs Global
KO:001250
|
-0.039x |
|
Ampire Co Ltd
TWO:8049
|
0.062x |
|
DCW Limited
NSE:DCW
|
0.123x |
Annual Cash Flow Conversion Efficiency for Treace Medical Concepts Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Treace Medical Concepts Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $112.89 Million | $-37.17 Million | -0.329x | -31.35% |
| 2023-12-31 | $137.94 Million | $-34.58 Million | -0.251x | +50.50% |
| 2022-12-31 | $60.53 Million | $-30.65 Million | -0.506x | -174.10% |
| 2021-12-31 | $93.07 Million | $-17.19 Million | -0.185x | +96.81% |
| 2020-12-31 | $776.00K | $-4.49 Million | -5.791x | -138.58% |
| 2019-12-31 | $3.16 Million | $-7.67 Million | -2.427x | -- |